Publicaciones (75) Publicaciones en las que ha participado algún/a investigador/a

2020

  1. 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the Treatment of Pain

    Journal of Medicinal Chemistry, Vol. 63, Núm. 5, pp. 2434-2454

  2. A meta-analysis of preclinical studies using antioxidants for the prevention of cisplatin nephrotoxicity: implications for clinical application

    Critical Reviews in Toxicology, Vol. 50, Núm. 9, pp. 780-800

  3. A missense in HSF2BP causing primary ovarian insufficiency affects meiotic recombination by its novel interactor c19orf57/brme1

    eLife, Vol. 9, pp. 1-93

  4. A novel serum metabolomic profile for the differential diagnosis of distal cholangiocarcinoma and pancreatic ductal adenocarcinoma

    Cancers, Vol. 12, Núm. 6

  5. Acquired haemophilia a in association with influenza a and urinary tract infection

    European Journal of Case Reports in Internal Medicine, Vol. 7, Núm. 9

  6. Angiogenesis in cardiopulmonary dirofilariosis: Does the Wolbachia surface protein have a pro-or anti-angiogenic effect?

    Journal of Helminthology

  7. Association of Alk1 and Endoglin Polymorphisms with Cardiovascular Damage

    Scientific Reports, Vol. 10, Núm. 1

  8. Blockade of 5-HT2 receptors with sarpogrelate uncovers 5-HT7 receptors inhibiting the tachycardic sympathetic drive in pithed rats

    Clinical and Experimental Pharmacology and Physiology, Vol. 47, Núm. 3, pp. 403-411

  9. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

  10. Care dependency in patients with heart failure: A cross-sectional study in Spain

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 19, pp. 1-8

  11. Cellular mechanisms accounting for the refractoriness of colorectal carcinoma to pharmacological treatment

    Cancers, Vol. 12, Núm. 9, pp. 1-34

  12. Cholangiocarcinoma 2020: the next horizon in mechanisms and management

    Nature Reviews Gastroenterology and Hepatology, Vol. 17, Núm. 9, pp. 557-588

  13. Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma

    HEPATOBILIARY SURGERY AND NUTRITION

  14. Cold-atmospheric plasma induces tumor cell death in preclinical in vivo and in vitro models of human cholangiocarcinoma

    Cancers, Vol. 12, Núm. 5

  15. Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury

    Scientific Reports, Vol. 10, Núm. 1

  16. Continuous endoglin (CD105) overexpression disrupts angiogenesis and facilitates tumor cell metastasis

    Angiogenesis, Vol. 23, Núm. 2, pp. 231-247

  17. Corrigendum to ‘P-Glycoprotein activation by 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5) in rat distal ileum: Ex vivo and in vivo studies’ [Toxicology and Applied Pharmacology 386 (2020) 114832] (Toxicology and Applied Pharmacology (2020) 386, (S0041008X19304405), (10.1016/j.taap.2019.114832))

    Toxicology and Applied Pharmacology

  18. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

    British Journal of Cancer, Vol. 123, Núm. 7, pp. 1047-1059

  19. Design of an interface for teaching cardiovascular physiology to anesthesia clinicians with a patient simulator connected to a minimally invasive cardiac output monitor (LiDCO rapid®)

    Advances in Simulation, Vol. 5, Núm. 1

  20. Designing new diagnostic systems for the early detection of tobacco-associated chronic renal damage in patients of a primary care centre in Salamanca, Spain: An observational, prospective study protocol

    BMJ Open, Vol. 10, Núm. 3